Gan & Lee Showcases Metabolic Pipeline Data at ADA 2026
NEW ORLEANS, Louisiana, June 11, 2026 Gan & Lee Pharmaceuticals presented four significant research findings from its innovative metabolic...
Alzheimer’s Disease artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma Biotechnology Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Eli Lilly FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology oncology innovation Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory compliance targeted therapy
NEW ORLEANS, Louisiana, June 11, 2026 Gan & Lee Pharmaceuticals presented four significant research findings from its innovative metabolic...
MELBOURNE, Australia, June 11, 2026 Scientists have identified Lanthionine Synthetase C-Like Protein 1 (LANCL1) as a promising new therapeutic...
CAMBRIDGE, Massachusetts, ROTTERDAM, Netherlands, and SHANGHAI, China, June 14, 2026 Harbour BioMed has secured a major legal victory in...
MARLBOROUGH, Mass., June 1, 2026 SCIEX, a Danaher company and a global leader in life science analytical technologies, announced...
HOUSTON, June 1, 2026 Iterion Therapeutics has unveiled compelling clinical data supporting tegavivint, its first-in-class Wnt/β-catenin pathway inhibitor, as...
SANTA CLARA, Calif., June 1, 2026 Agilent Technologies and Sound Analytics have announced a strategic collaboration aimed at transforming...
FORT LAUDERDALE, Fla., May 29, 2026 Sunshine Biopharma announced that the United States Patent and Trademark Office has issued...
SOUTH SAN FRANCISCO, California, May 27, 2026 Human Longevity, Inc. (HLI) has announced the creation of Human Life Foundation...
PORTLAND, Oregon, May 20, 2026 Araceli Biosciences announced the launch of Endeavor® Live Cell, a new ultra-high-throughput kinetic imaging...
PARIS and CAMBRIDGE, UK, May 13, 2026 AndzonBio2 announced a strategic collaboration with the ALBORADA Drug Discovery Institute (ADDI)...
